Matches in DBpedia 2014 for { ?s ?p The Court held that the use of patented compounds in preclinical studies is protected under §271 at least as long as there is a reasonable basis to believe that the compound tested could be the subject of an FDA submission and the experiments will produce the types of information relevant to an IND or NDA.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Merck_KGaA_v._Integra_Lifesciences_I,_Ltd. holding "The Court held that the use of patented compounds in preclinical studies is protected under §271 at least as long as there is a reasonable basis to believe that the compound tested could be the subject of an FDA submission and the experiments will produce the types of information relevant to an IND or NDA.".